174 related articles for article (PubMed ID: 1691406)
21. The safety and tolerability of quinapril.
Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
[TBL] [Abstract][Full Text] [Related]
22. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
Maclean D
Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
[TBL] [Abstract][Full Text] [Related]
23. Overall tolerance and safety of quinapril in clinical trials.
Frank GJ; Knapp LE; McLain RW
Angiology; 1989 Apr; 40(4 Pt 2):405-15. PubMed ID: 2650583
[TBL] [Abstract][Full Text] [Related]
24. Quinapril: a new second-generation ACE inhibitor.
Cetnarowski-Cropp AB
DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
[TBL] [Abstract][Full Text] [Related]
25. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
Hausberg M; Barenbrock M; Hohage H; Müller S; Heidenreich S; Rahn KH
Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
[TBL] [Abstract][Full Text] [Related]
26. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
Romero R; Castellote E; Ocón J; Wagner B
J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
[TBL] [Abstract][Full Text] [Related]
27. Overview of the clinical development of quinapril.
Frank GJ
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
[TBL] [Abstract][Full Text] [Related]
29. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH
Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836
[TBL] [Abstract][Full Text] [Related]
30. The treatment of moderate to severe hypertension with ACE inhibitors.
Goldstein RJ
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S29-35. PubMed ID: 1691404
[TBL] [Abstract][Full Text] [Related]
31. The effect of quinapril on functional status of elderly patients with diastolic heart failure.
Zi M; Carmichael N; Lye M
Cardiovasc Drugs Ther; 2003 Mar; 17(2):133-9. PubMed ID: 12975595
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
Frishman WH; Greenberg S
Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension.
Taylor SH
Angiology; 1989 Apr; 40(4 Pt 2):382-8. PubMed ID: 2539763
[TBL] [Abstract][Full Text] [Related]
34. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
[TBL] [Abstract][Full Text] [Related]
35. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
Gadzhiev AN
Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
[TBL] [Abstract][Full Text] [Related]
36. The management of hypertension in older patients.
Schnaper HW
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S56-61. PubMed ID: 1691408
[TBL] [Abstract][Full Text] [Related]
37. The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
Frishman WH
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII19-25. PubMed ID: 2189617
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
[TBL] [Abstract][Full Text] [Related]
39. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
Bahena JH; Estrella ME; Muñoz M
Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
[TBL] [Abstract][Full Text] [Related]
40. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
Jondeau G; Dib JC; Dubourg O; Bourdarias JP
Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
